Cargando…
Protocol for analyses of adverse event data from randomized controlled trials of statin therapy
The Cholesterol Treatment Trialists' (CTT) Collaboration was originally established to conduct individual participant data meta-analyses of major vascular events, cause-specific mortality, and site-specific cancers in large, long-term, randomized trials of statin therapy (and other cholesterol-...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Mosby
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906243/ https://www.ncbi.nlm.nih.gov/pubmed/27264221 http://dx.doi.org/10.1016/j.ahj.2016.01.016 |
Ejemplares similares
-
Assessing Muscle-Related Adverse Events in Randomized Trials of Statins
por: Doshi, Peter, et al.
Publicado: (2022) -
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials
por: Preiss, David, et al.
Publicado: (2015) -
Adverse Event Reporting in Randomized Clinical Trials for Multiple Myeloma
por: Najjar, Mimi, et al.
Publicado: (2023) -
Genetic variants in the KIF6 region and coronary event reduction from statin therapy
por: Li, Yonghong, et al.
Publicado: (2010) -
Harmonisation of large-scale, heterogeneous individual participant adverse event data from randomised trials of statin therapy
por: Cholesterol Treatment Trialists’ Collaboration,
Publicado: (2022)